WIN 51711, a new systematically active broad-spectrum antipicornavirus agent.

Suppr

超能文献

作者信息

McKinlay M A

出版信息

J Antimicrob Chemother. 1985 Sep;16(3):284-6. doi: 10.1093/jac/16.3.284.

DOI:10.1093/jac/16.3.284

PMID:4055541

Abstract

摘要

相似文献

WIN 51711, a new systematically active broad-spectrum antipicornavirus agent.

J Antimicrob Chemother. 1985 Sep;16(3):284-6. doi: 10.1093/jac/16.3.284.

In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.新型广谱抗微小核糖核酸病毒药物WIN 51711的体外活性

Antimicrob Agents Chemother. 1985 Jun;27(6):883-6. doi: 10.1128/AAC.27.6.883.

Isoxazoles with antipicornavirus activity.

J Med Chem. 1985 Jun;28(6):748-52. doi: 10.1021/jm00383a010.

In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.新型广谱抗微小核糖核酸病毒药物WIN 54954的体外和体内活性

Antimicrob Agents Chemother. 1989 Dec;33(12):2069-74. doi: 10.1128/AAC.33.12.2069.

Antipicornavirus activity of tetrazole analogues related to disoxaril.与双异丙酚相关的四唑类似物的抗微小核糖核酸病毒活性

J Med Chem. 1993 Oct 29;36(22):3240-50. doi: 10.1021/jm00074a004.

Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.新型抗病毒药物WIN 51711对鼻病毒和脊髓灰质炎病毒脱壳的预防作用

Antimicrob Agents Chemother. 1986 Jul;30(1):110-6. doi: 10.1128/AAC.30.1.110.

SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.SCH 38057：一种在病毒脱壳初始阶段后具有抗病毒活性的小核糖核酸病毒衣壳结合分子。

Antiviral Res. 1993 May;21(1):15-35. doi: 10.1016/0166-3542(93)90064-p.

Chiral discrimination and antipicornavirus activity of 6-oxazolinylisoflavan.6-恶唑啉基异黄酮的手性识别及抗小RNA病毒活性

Chirality. 1993;5(5):356-8. doi: 10.1002/chir.530050515.

Inhibition of poliovirus uncoating by disoxaril (WIN 51711).双异丙氧乙酰胺（WIN 51711）对脊髓灰质炎病毒脱壳的抑制作用。

Virology. 1987 Sep;160(1):281-5. doi: 10.1016/0042-6822(87)90075-4.

Picornavirus inhibitors: trifluoromethyl substitution provides a global protective effect against hepatic metabolism.小核糖核酸病毒抑制剂：三氟甲基取代对肝脏代谢具有全面的保护作用。

J Med Chem. 1995 Apr 14;38(8):1355-71. doi: 10.1021/jm00008a014.

引用本文的文献

Targeting the Virus Capsid as a Tool to Fight RNA Viruses.靶向病毒衣壳作为抗击 RNA 病毒的工具。

Viruses. 2022 Jan 18;14(2):174. doi: 10.3390/v14020174.

Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.回到未来：广谱肠道病毒衣壳结合抑制剂的研发进展。

Eur J Med Chem. 2019 Sep 15;178:606-622. doi: 10.1016/j.ejmech.2019.06.008. Epub 2019 Jun 11.

Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone.肠道病毒71型衣壳蛋白VP1的突变赋予了对吡啶基咪唑啉酮抑制作用的抗性。

Antimicrob Agents Chemother. 2004 Sep;48(9):3523-9. doi: 10.1128/AAC.48.9.3523-3529.2004.

WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present.3型脊髓灰质炎病毒的WIN 51711依赖性突变体：有证据表明，除非有药物存在，病毒粒子从细胞释放后会发生衰变。

J Virol. 1993 Mar;67(3):1246-54. doi: 10.1128/JVI.67.3.1246-1254.1993.

Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions.3型脊髓灰质炎病毒耐药性突变的分布确定了三个参与脱壳功能的区域。

J Virol. 1994 Dec;68(12):8193-201. doi: 10.1128/JVI.68.12.8193-8201.1994.

Picornavirus inhibitors.小核糖核酸病毒抑制剂

Pharmacol Ther. 1994;64(2):215-90. doi: 10.1016/0163-7258(94)90040-x.

In vitro antiviral activity of the 6-substituted 2-(3',4'-dichlorophenoxy)-2H-pyrano[2,3-b]pyridines MDL 20,610, MDL 20,646, and MDL 20,957.6-取代的2-(3',4'-二氯苯氧基)-2H-吡喃并[2,3-b]吡啶MDL 20,610、MDL 20,646和MDL 20,957的体外抗病毒活性

Antimicrob Agents Chemother. 1986 Sep;30(3):516-8. doi: 10.1128/AAC.30.3.516.

Mechanism of action of the antiviral compound MDL 20,610.抗病毒化合物MDL 20,610的作用机制。

Antiviral Res. 1988 Jul;9(4):249-61. doi: 10.1016/0166-3542(88)90056-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验